Skip to main content
. Author manuscript; available in PMC: 2009 Jul 15.
Published in final edited form as: J Immunol. 2008 Jul 15;181(2):954–968. doi: 10.4049/jimmunol.181.2.954

FIGURE 9.

FIGURE 9

IL-13 produced from mice adoptively transferred with Treg cells from Salmonella-CFA/IIC (AP331)-immunized mice protects against EAE. Cell-sorted 6 × 105 Treg cells from Salmonella vector (H647)- and AP331-immunized SJL mice were adoptively transferred (i.v.) into naïve SJL recipient mice, and one day later, EAE was induced with PLP139–151. To neutralize IL-13, rabbit antiserum (0.5 ml) was given one day before EAE induction, and two additional doses (0.25 ml each) were given on days 1 and 5 post-EAE challenge (thick arrows). Equivalent volumes of normal rabbit serum (NRS) were given to control groups. In vivo neutralization of IL-13 of recipient mice given AP331-induced Treg cells reversed the protection conferred by these T cells, and their clinical scores resembled mice adoptively transferred with H647-induced Treg cells. Anti-IL-13 treatment had no impact upon EAE in PBS-treated or mice adoptively transferred with Treg cells from H647-immunized mice. NRS treatments had no negative impact upon the various treated groups. Depicted results are from a total of 5 mice/group. *, P < 0.001, for anti-IL-13 vs. NRS treatment with the adoptively transferred Treg cell groups; , P < 0.001 for PBS vs. anti-IL-13 and NRS treatment with the adoptively transferred Treg cell groups.